M Zschiesche - Concepedia

Author

M Zschiesche

Universität Greifswald

Also Known As

M ZSCHIESCHE, M Zschiesche, M. Zschiesche, M. Zschiesche, MICHAEL ZSCHIESCHE, Michael Zschiesche

Publications

975

Citations

H-Index

Concepts

All Affiliations

Universität Greifswald Universitätsmedizin Greifswald University of Rostock Johannes Gutenberg University Mainz

About

M Zschiesche is an author at Universität Greifswald specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	235
2	Biochemistry	4	4	123
3	Gastroenterology	2	2	104
4	Natural Sciences	1	1	53
5	Social Sciences	1	1	39

M Zschiesche

Publications

789

Citations

H-Index

Page 1

	Year	Citations
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans K. May, Danilo Wegner, Ute Hecker, Clinical Pharmacology & Therapeutics	2004	165
<i>CYP2D6</i>genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects Ute Hecker, M Zschiesche, Peter Dazert, Clinical Pharmacology & Therapeutics	2004	128
Circadian Rhythm of Serum Cortisol after Repeated Inhalation of the New Topical Steroid Ciclesonide Anita Weinbrenner, Dagny Hüneke, M Zschiesche, The Journal of Clinical Endocrinology & Metabolism	2002	89
A new fluorimetric enzyme assay for the diagnosis of Niemann–Pick A/B, with specificity of natural sphingomyelinase substrate O. P. van Diggelen, Ya. V. Voznyi, J. L. M. Keulemans, Journal of Inherited Metabolic Disease	2005	76
The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen Werner Weitschies, Annika Bernsdorf, M Zschiesche, Pharmaceutical Research PhysiologyGastroenterologyPathologyPresystemic ProcessingMetabolism	2005	68
Niemann-Pick Disease Type A and B are Clinically but also Enzymatically Heterogeneous: Pitfall in the Laboratory Diagnosis of Sphingomyelinase Deficiency Associated with the Mutation Q292 K K. Harzer, Arndt Rolfs, Peter Bauer, Neuropediatrics Neurological DisorderGeneticsMolecular BiologyPathologySphingomyelin Substrate	2003	53
Effect of levothyroxine administration on intestinal P‐glycoprotein expression: Consequences for drug disposition* Werner Siegmund, Stephan Altmannsberger, Andrea Paneitz, Clinical Pharmacology & Therapeutics	2002	47
Stereoselective disposition of talinolol in man M Zschiesche, G Lemma, K.-J. Klebingat, Journal of Pharmaceutical Sciences Psychoactive DrugStereoselective DispositionPsychologyPsychopharmacologyPharmacotherapy	2002	39
Variability of Intestinal Expression of P-Glycoprotein in Healthy Volunteers as Described by Absorption of Talinolol from Four Bioequivalent Tablets Werner Siegmund, Karen Ludwig, Georg Engel, Journal of Pharmaceutical Sciences GlycosylationBiochemistryMedicineHealthy VolunteersBioanalysis	2003	36
Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine Christian Müller, Werner Siegmund, Risto Huupponen, European Journal of Drug Metabolism and Pharmacokinetics BiochemistryMedicineRadioreceptor AssayMass SpectrometryExtensive Metabolizers	1993	20

Page 1